INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2018

Serum 25-hydroxyvitamin D concentrations of ≥60 vs <20 ng/ml were linked to an 80% lower risk of breast cancer in women aged 55 and older.

Researchers analyzed pooled data from two randomized clinical trials (N = 1,129 and N = 2,196) and a prospective cohort (N = 1,713) to examine the relationship between serum 25(OH)D levels and breast cancer risk over a median of 4.0 years. Across the pooled cohort of 5,038 women, 77 breast cancer cases were diagnosed. Women with 25(OH)D concentrations ≥60 ng/ml had an 82% lower incidence rate compared to those with <20 ng/ml (RR = 0.18, P = 0.006). In multivariate Cox regression adjusting for age, BMI, smoking, calcium supplement intake, and study of origin, concentrations ≥60 ng/ml were associated with an 80% lower risk of breast cancer versus <20 ng/ml (HR = 0.20, P = 0.03).

Shows an association, not proof of cause and effect.

Study type
Pooled cohort analysis
Who was studied
5,038 women aged 55 years and older
What was measured
Diagnosis of breast cancer

THE PAPER

Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.

McDonnell SL, Baggerly CA, French CB, Baggerly LL, Garland CF, Gorham ED, Hollis BW, Trump DL, Lappe JM. PLoS One, 2018.

PubMed 29906273 ↗DOI 10.1093/jnci/djq495 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.